Market News AIOpen the app

Eton Pharmaceuticals is starting a new program to test ET-900 for treating infantile and epileptic spasms.

TrialPRORead the original at SEC EDGAR
Good or bad for ETON?

This is a Prominent story. The full analysis, including whether it is good or bad for ETON, is available with Pro or after its release time. It opens to free readers on Nov 3, 2026, 7:05 AM ET.

Get alerts for ETON

Follow Eton Pharmaceuticals, Inc. (ETON) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ETON
Free on the App Store and Google Play, or on the web.